CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders
Casein kinases are involved in a variety of signaling pathways, and also in inflammation, cancer, and neurological diseases. Therefore, they are regarded as potential therapeutic targets for drug design. Recent studies have highlighted the importance of the casein kinase 1 superfamily as well as pro...
Main Authors: | Andrea Baier, Ryszard Szyszka |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmolb.2022.916063/full |
Similar Items
-
Yeast Protein Asf1 Possesses Modulating Activity towards Protein Kinase CK2
by: Andrea Baier, et al.
Published: (2022-12-01) -
Protein kinase CK2 from two higher eukaryotes of economical importance, the mussel Mytilus galloprovincialis and the medfly Ceratitis capitata
by: Kouyanou-Koutsoukou Sophia, et al.
Published: (2012-04-01) -
CK2—An Emerging Target for Neurological and Psychiatric Disorders
by: Julia Castello, et al.
Published: (2017-01-01) -
TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients
by: Loreto Martinez-Gonzalez, et al.
Published: (2023-08-01) -
Protein Kinase CK2α’, More than a Backup of CK2α
by: Mathias Montenarh, et al.
Published: (2023-12-01)